Company Info
Phone(833) 475-8247
Year Established
2009
Ticker
GRI
Exchange
NASDAQ
Contacts
Marc Hertz, PhDPresident & CEO
Vipin Kumar Chaturvedi, PhD
CSO
Albert Agro, PhD
CMO
Leanne Kelly
CFO
Company Description
GRI Bio is advancing an innovative pipeline of NKT cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases.
